73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs
Immunotherapy with two novel drugs shows activity in colorectal cancer

Immunotherapy with two novel drugs shows activity in colorectal cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA combination of two next-generation immunotherapy drugs has shown promising clinical activity in treating patients with refractor

Immunotherapy with two novel drugs shows activity in colorectal cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainA combination of two next-generation immunotherapy drugs has shown promising clinical activity in treating patients with refractor
Researchers uncover novel aspect of tumor evolution and potential targets for therapy

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s
A barrier that keeps cancer at bay

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t

A barrier that keeps cancer at bay

by Ecole Polytechnique Federale de LausanneLoss of a barrier to tumor formation: On the left, a protective barrier of activin B expression (red color) is present in normal pancreatic islets. On t
Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre

Identifying drug target candidates to treat pediatric rhabdomyosarcoma tumors

by Thamarasee Jeewandara , Medical XpressscRNAseq of RMS identifies heterogeneity recapitulating muscle developmental programs. (A) Experimental workflow. (B) UMAP plot of 48,859 RMS cells after regre
Research team develops novel strategy to suppress prostate cancer growth

Research team develops novel strategy to suppress prostate cancer growth

by Aaron Nieto,Baylor College of MedicineProstate cancer cells. Credit: NIH Image GalleryFinding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Y

Research team develops novel strategy to suppress prostate cancer growth

by Aaron Nieto,Baylor College of MedicineProstate cancer cells. Credit: NIH Image GalleryFinding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Y
CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres
Researchers find key to help treat different cancers

Researchers find key to help treat different cancers

by Yale UniversityYale Cancer Center (YCC) scientists have uncovered the workings of a metabolic pathway or "gauge" that lets cancer cells detect when they have enough nutrients around

Researchers find key to help treat different cancers

by Yale UniversityYale Cancer Center (YCC) scientists have uncovered the workings of a metabolic pathway or "gauge" that lets cancer cells detect when they have enough nutrients around
How the body fights cancer and intruders

How the body fights cancer and intruders

by Lori Dajose,California Institute of TechnologyT cells surround a cancer cell. Credit: National Institutes of HealthThe human body's immune system is like a vast team of special agents. Ce

How the body fights cancer and intruders

by Lori Dajose,California Institute of TechnologyT cells surround a cancer cell. Credit: National Institutes of HealthThe human body's immune system is like a vast team of special agents. Ce
Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous

Gel-like, radioactive tumor implant obliterates pancreatic cancer in mice

by Ken Kingery,Duke UniversityCredit: Unsplash/CC0 Public DomainBiomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mous
Blood test for brain cancer may be on horizon, research finds

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at
Clinical trial could lead to new 'gold standard' test for prostate cancer detection

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

by Gillian Rutherford,University of AlbertaCredit: MART PRODUCTION from PexelsA University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining th

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

by Gillian Rutherford,University of AlbertaCredit: MART PRODUCTION from PexelsA University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining th